Modern application possibilities hopanthenic acid (Pantocalcin) in treatmentdiseases of the nervous system in children

Nemkova S.A.

doi:https://doi.org/10.17116/jnevro202212205169

Close metadata

Recommended articles:

Modern approaches to diagnosis and treatment of postinfectious asthenic syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):42-52

Pathogenetic aspects of autoantibody formation to central nervous system structures in patients with encephalitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):53-58

Insomnia in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):46-51

Clinical and instrumental diagnostics of facial neuropathy in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):31-36

Risk factors of unfavorable outcome after decompressive craniectomy in children with severe traumatic brain injury. Burdenko's Journal of Neurosurgery. 2025;(3):42-47

Pathomorphology of chronic polypous purulent rhinosinusitis in cystic fibrosis in children. Russian Rhinology. 2025;(2):101-110

Dynamics of endotracheal tube cuff pressure during general anesthesia with xenon in children in outpatient dental practice. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):50-54

Liver involvement in Gaucher disease in children: A literature review and clinical observations. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):78-93

Associations between salivary minerals concentrations and caries experience among 12-years old children in Syktyvkar, Komi Republic. Russian Journal of Stomatology. 2025;(2):34-38

Possibilities for optimizing preventive and therapeutic dental care for the pediatric population of Chapayevsk using SWOT analysis. Russian Journal of Stomatology. 2025;(2):39-44

Abstract:

The review analyzes the current possibilities of using hopanthenic acid (Pantocalcin) in the treatment of diseases of the nervous system in children (perinatal CNS lesions, developmental delays, cerebral palsy, ADHD, tics, enuresis, cognitive and neurotic disorders), taking into account modern standards and clinical recommendations. The results of numerous studies demonstrate that Pantocalcin is a highly effective and safe drug in the treatment of diseases of the nervous system in children with complex neurometabolic, neuroprotective, neurotrophic properties.

Keywords:

hopanthenic acid

Pantocalcin

diseases of the nervous system

children

cerebral palsy

ADHD

tics

Authors:

Nemkova S.A.

Pirogov Russian National Research Medical University

Received:

10.03.2022

Accepted:

25.03.2022

Close metadata

References:

Zdravoohranenie v Rossii, 2021. Statisticheskij sbornik. Rosstat. M. 2021. (In Russ.).
Detskaya nevrologiya. Klinicheskie rekomendacii. Pod red. Guzevoj VI. M.: IMK; 2014. (In Russ.).
Federal’noe rukovodstvo po detskoj nevrologii. Pod red. Guzevoj V.I. M.: IMK; 2016. (In Russ.).
Sosina VB. Possibilities and prospects of pantocalcin application in clinical practice. RMZh. 2006;2:109-111. (In Russ.).
Nakahiro M., et al. Pantoyl-gamma-aminobutyric acid facilitates cholinergic function in the central nervous system.Journal of Pharmacology and Experimental Therapeutics. 1985;232(2):501-506.
Ogawa N., et al. Effects of calcium hopantenate on neurotransmitter receptors in the rat brain //The Japanese Journal of Pharmacology. 1985;37(1):45-50.
Instructions for the medical use of the drug Pantocalcin (tablets and solution for oral administration).
Muratova NV. Pantocalcin: areas of clinical application. Russian Medical Journal. 2007;10:868-873.
Balakireva EA, Neretina AF, Krasnoruckaya ON, et al. Experience of using Pantocalcin in the practice of a pediatric neurologist. Farmateka. 2014;11:8-12. (In Russ.).
Lazebnik TA, Rumyanceva VN, Shejde NA, et al. Correction of speech disorders in preschool children using pantocalcin. Trudnyj Pacient. 2010;8(9):33-36. (In Russ.).
Smagulova AR, Kadrzhanova GB, Izbasarova ASh. Experience of using the drug «pantocalcin» with delayed speech development in children. Farmaciya Kazahstana. 2015;1(164):53-55. (In Russ.).
Zykov VP, Kashirina ES, Naugolnykh YuV. Objective methods for evaluating the efficacy of treatment in children with tics. Nevrologicheskiy Vestnik. 2016;2:35-41. (In Russ.).
Zykov VP, Amirhanova DYu, Novikova EB, et al. Pantocalcin in the treatment of chronic tics in children. Russkij Zhurnal Detskoj Nevrologii. 2010;5(1):19-26. (In Russ.).
Kabanova SA. The use of the drug «Pantocalcin» in the therapy of children with tic hyperkinesis. Farmaciya Kazahstana. 2014;9(160):25-27. (In Russ.).
Zykov VP, Begasheva OI. Current concepts in the diagnosis of attention deficit hyperactivity disorder and experience of its treatment with hopantenic acid. Consilium Medicum. 2017;1:114-118. (In Russ.).
Baranov AA, Al’bickij VYu, Modestov AA, et al. Morbidity of the Russian child population (results of a comprehensive medical and statistical study). Zdravoohranenie Rossijskoj Federacii. 2012;5:21-26. (In Russ.).
Bombardirova EP, Yacyk GV. Perinatal lesions of the central nervous system in newborns. Selected lectures on pediatrics. Pod red. Baranova AA, Shilyaeva RR, Kaganova BS. M.: Dinastiya; 2005. (In Russ.).
Studenikin VM, Shelkovskij VI, Hachatryan LG, Andreenko NV. About perinatal lesions of the nervous system and outcomes. Praktika Pediatra. 2008;1:24-28. (In Russ.).
Classification of perinatal lesions of the nervous system and their consequences in children of the first year of life. Methodological recommendations. Pod red. Volodina NN. M.: VUNMC; 2006. (In Russ.).
Palchik AB, Shabalov NP. Hypoxic-ischemic encephalopathy of newborns. M.: MEDpress-inform; 2006. (In Russ.).
Petruhin AS. Neurology of childhood. M.: Medicina; 2004. (In Russ.).
Bowery NG. GABAB receptor: a site of therapeutic benefit. Curr Opin Pharmacol. 2006;6:37-43.
Nemkova SA. Modern principles of complex diagnostics and rehabilitation of perinatal lesions of the nervous system and their consequences. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(3):40-49. (In Russ.). https://doi.org/10.17116/jnevro20171173140-49
Nemkova SA, Zavadenko NN, Medvedev MI. Modern principles of early diagnosis and comprehensive treatment of perinatal lesions of the central nervous system and cerebral palsy. Methodical manual. M.: GBOU VPO RNIMU im. N.I. Pirogova MZ RF; 2013. (In Russ.).
Federal clinical guidelines for the provision of medical care to children with the consequences of perinatal damage to the central nervous system with diffuse muscular hypotension. M.: Soyuz pediatrov Rossii; 2013. (In Russ.).
Lazebnik TA, Rumyanceva VN, Shejde NA, et al. Correction of speech disorders in preschool children using Pantocalcin. Effektivnaya Farmakoterapiya v Pediatrii. 2010;1:12-16. (In Russ.).
Lazebnik TA, Rumyanceva VN, Shejde NA, et al. Correction of speech disorders in preschool children using Pantocalcin. Medicinskie Novosti. 2011;3:64-67. (In Russ.).
Nemkova SA. Cerebral palsy: early diagnosis and rehabilitation treatment. Lechashchij Vrach. 2016;5:24-29. (In Russ.).
Nemkova SA. Cerebral palsy: modern technologies in the complex diagnosis and rehabilitation of cognitive disorders. M.: Medpraktika-M; 2013. (In Russ.).
Semenova KA. Restorative treatment of children with perinatal damage to the nervous system and with cerebral palsy. M.: Zakon i poryadok; 2007. (In Russ.).
Kancherla V, Amendah DD, Grosse S.D, et al. Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children. Res Dev Disabil. 2012;33(3):832-840.
Nemkova SA. Disorders of mental development in cerebral palsy: comprehensive diagnosis and correction. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2018;118(2):105-113. (In Russ.). https://doi.org/10.17116/jnevro201811821105-113
Nemkova SA. Cognitive impairment in cerebral palsy. M.: Triada-H; 2013. (In Russ.).
Nemkova SA, Maslova OI, Zavadenko NN, et al. Cognitive disorders in children with cerebral palsy (structure, diagnosis, treatment). Pediatricheskaya Farmakologiya. 2012;9(3):77-84. (In Russ.).
Nemkova SA, Namazova-Baranova LS, Maslova OI, et al. Cerebral palsy: diagnosis and correction of cognitive disorders. Soyuz pediatrov Rossii. M.; 2012. (In Russ.).
Nemkova SA, Maslova OI, Zavadenko NN, Karkashadze GA. Features of diagnosis and rehabilitation of cognitive disorders in children with cerebral palsy. Detskaya i Podrostkovaya Reabilitaciya. 2012;1:14-15. (In Russ.).
Zavadenko NN, Nemkova SA. Developmental disorders and cognitive dysfunctions in children with diseases of the nervous system. M.: MedPressInform; 2016. (In Russ.).
Batysheva TT, Platonova AN, Chebanenko NV, Bykova OV. Correction of cognitive impairment in children and adolescents with cerebral palsy during treatment with pantocalcin. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2013;113(9):48-53. (In Russ.).
Bykov YuV, Becker RA. Prospects for the use of hopanthenic acid in psychiatric practice. Consilium Medicum. 2018;20(2):112-123. (In Russ.). https://doi.org/10.26442/2075-1753_2018.2.112-123.
Tumashenko AF. Efficacy of Pantocalcin in the treatment of attention deficit hyperactivity disorder in children and adolescents. Consilium Medicum. Pediatriya. 2006;2:56-58. (In Russ.).
Musatova NP. Pantocalcin in the treatment of attention deficit hyperactivity disorder. Trudnyy Patsient. 2006;4(6):2-3. (In Russ.).
Kazbekova MT. Attention to children suffering from attention deficit hyperactivity disorder. Nauka i Zdravoohranenie. 2010;4:85-86. (In Russ.).
Miarkovskaia OI, Miarkovskii VA, Nurova ShT, et al. Pantokal’tsin v kompleksnoi terapii u giperaktivnykh detei s iavleniiami defitsita vnimaniia. Vestn. Almatinskogo gos. in-ta Usovershenstvovaniia Vrachei. 2010;1(9):63-64. (In Russ.).
Chutko LS, Surushkina SYu, Nikishena IS, et al. Treatment of attention deficit syndrome with comorbid tic hyperkinesis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2008;108(2):45-48. (In Russ.).
Pylaeva OA, Shatenstein AA, Mukhin KYu. Attention deficit hyperactivity disorder: concomitant diseases, emphasis on combination with epilepsy. Russkij Zhurnal Detskoj Nevrologii. 2018;13(3):57-74. (In Russ.).
Chekalova SA, Vorobyeva VA, Bogomolova ES, et al. Modern view on the problem of school adaptation. Remedium Privolzh’e. 2014;5(125):24-27. (In Russ.).
Kudlach AI, Shalkevich LV, Simonenko AV, et al. Pathological redundancy of motor act: modern ideas about pathogenesis and approaches to drug correction. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova, 2017;117(11):168-173. (In Russ.). https://doi.org/10.17116/jnevro2017117111161-167
Zykov VP. Tics of childhood. M.: MBN; 2008. (In Russ.).
Chutko LS. Tics in children. SPb.: Elbi-SPb; 2008. (In Russ.).
Ermolenko NA, Zakharova EI, Ermakov AYu. Tics in children and adolescents, comorbidity with epilepsy. Nauchnye Vedomosti. Seriya Medicina. Farmaciya. 2015;4(201):29:23-26. (In Russ.).
Müller-Vahl KR. Lateral frontal cortex volume reduction in Tourette syndrome revealed by VBM. Neuroscience. 2012;14:13-17.
Chao HT, Chen H, Samaco RC, et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature. 2010;468(7321):263-269. https://doi.org/10.1038/nature09582
Lewis M, Kim SJ. The pathophysiology of restricted repetitive behavior. Journal of Neurodevelopmental Disorders. 2009;1(2):114-132. https://doi.org/10.1007/s11689-009-9019-6
Garmanova TN, Shaderkina VA. Enuresis — theoretical foundations and practical recommendations. Eksperimental’naya i Klinicheskaya Urologiya. 2014;8:102-106. (In Russ.).
Gulyamova MA. Enuresis: Etiology, Pathophysiology and Treatment. Journal of Advanced Medical and Dental Sciences Research. 2020;8(12):114-117.
Kazanskaya IV, Pospuschennikova TV. Substantiation of therapeutic tactics of enuresis in children with hyperactive bladder. Russkij Medicinskij Zhurnal. 2006;16:1199-1204. (In Russ.).
Zastelo ES, Tush EV, Khaletskaya OV. Conservative treatment of vesicoureteral reflux in a 10-year-old child. Sovremennye Tekhnologii v Medicine. 2013;5(3):119-121. (In Russ.).
Borodin VI, Budtueva FS. The place of Pantocalcin in the complex therapy of enuresis in children. Trudnyj Pacient. 2006;4(9):33-36. (In Russ.).
Tlegenova A.T. The use of Pantocalcin in the treatment of children with enuresis. Zdorovje i Bolezn. 2011;3(98):120-122. (In Russ.).
Malyavin AG. Consequences of COVID-19 coronavirus infection: prevalence and approaches to the treatment of Long-COVID symptoms. Therapy. 2021;10:34-39. (In Russ.).
Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? The Pediatric Infectious Disease Journal. 2021;40(12):482-490.
Stephenson T. Long COVID — the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study. Researchsquare. 2021;45(6):56-61.
Brackel C. Pediatric long‐COVID: An overlooked phenomenon? Pediatric Pulmonology. 2021;56(8):2495-2502.
Laskov VB, Laskova IV. Astheno-vegetative dysfunction: manifestations and methods of correction in school-age children. Farmateka. 2014;7:280-284. (In Russ.).